High incidence of Androgenetic Alopecia among patients hospitalized due to severe COVID-19
Observational study on the high incidence of Androgenetic Alopecia among patients hospitalized due to severe COVID-19
In 2008 our office conducted a peer reviewed published study that showed the positive impact of low level light laser therapy for hair loss for men and women. Since then there have been multiple peer reviewed studies that have confirmed our findings. Many devices have been FDA approved and have been used effectively as a treatment option for hair loss in men and women. They can be used alone or in combination with other treatments for hair loss including PRP, minoxidil, and for men, finasteride.
Below is a link to my 2008 published study:
https://www.ncbi.nlm.nih.gov/pubmed/19466643
For more information, please call the office at 212-734-4007.
You Might Also Enjoy...
Observational study on the high incidence of Androgenetic Alopecia among patients hospitalized due to severe COVID-19
The attached study published in the Lancet regarding long-term clinical effects of recovered COVID-19 patients confirms what we have seen in our office over the past several months- increased rates in hair loss.
There appears to be a rare side effect of the new Moderna vaccine. It appears that there is a reaction between a filler and the vaccine induced immune response. The future will determine the precise incidence.
There has been a vastly increased number of people who had COVID in the spring that are now presenting with substantial hair loss.
Due to COVID-19 we are offering telemedicine appointments so that you can communicate with your doctor from the safety of your home.
Increasing reports of JAK inhibitors being used to treat alopecia areata.